BRIEF-Puma Biotechnology Reports Q4 Loss Per Share $0.38

路透社 · Feb 26, 2021 05:28

Feb 25 (Reuters) - Puma Biotechnology Inc :
   * PUMA BIOTECHNOLOGY REPORTS FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
   * Q4 ADJUSTED NON-GAAP LOSS PER SHARE $0.14
   * Q4 EARNINGS PER SHARE ESTIMATE $-0.29 -- REFINITIV IBES DATA
   * Q4 LOSS PER SHARE $0.38
   * Q4 REVENUE $52.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $52.8 MILLION
   * NET NERLYNX REVENUE IN Q4 OF 2020 WAS $50.0 MILLION, VERSUS $58.7 MILLION IN Q4 OF 2019

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

BRIEF-Puma Biotechnology Reports Q4 Loss Per Share $0.38

Risk Disclaimer